COPG2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.143400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.505000E-01
Normal-vs-Stage2
6.586800E-01
Normal-vs-Stage3
7.795000E-01
Normal-vs-Stage4
3.987000E-01
Stage1-vs-Stage2
9.684200E-01
Stage1-vs-Stage3
3.838800E-01
Stage1-vs-Stage4
3.565600E-01
Stage2-vs-Stage3
3.264800E-01
Stage2-vs-Stage4
3.272800E-01
Stage3-vs-Stage4
2.507600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.466000E-01
Normal-vs-AfricanAmerican
6.827400E-01
Normal-vs-Asian
2.979200E-01
Caucasian-vs-AfricanAmerican
9.803600E-01
Caucasian-vs-Asian
3.542900E-03
AfricanAmerican-vs-Asian
7.246300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.490200E-01
Normal-vs-Female
6.974200E-01
Male-vs-Female
4.499800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.119400E-01
Normal-vs-Age(41-60Yrs)
5.559400E-01
Normal-vs-Age(61-80Yrs)
6.934800E-01
Normal-vs-Age(81-100Yrs)
2.886000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.648400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.073400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.240400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.282400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.406630E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.002980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.845600E-01
Normal-vs-Daily Drinker
6.920000E-01
Normal-vs-Weekly Drinker
8.051600E-01
Normal-vs-Occasional Drinker
5.058600E-01
Normal-vs-Social Drinker
6.654600E-01
Non Drinker-vs-Daily Drinker
5.897800E-01
Non Drinker-vs-Weekly Drinker
8.488600E-01
Non Drinker-vs-Occasional Drinker
2.131400E-01
Non Drinker-vs-Social Drinker
4.815600E-01
Daily Drinker-vs-Weekly Drinker
7.841000E-01
Daily Drinker-vs-Occasional Drinker
4.588200E-01
Daily Drinker-vs-Social Drinker
8.011200E-01
Weekly Drinker-vs-Occasional Drinker
3.789200E-01
Weekly Drinker-vs-Social Drinker
6.569600E-01
Occasional Drinker-vs-Social Drinker
6.985800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.407400E-01
Normal-vs-Grade 2
1.031720E-02
Normal-vs-Grade 3
2.005900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.835200E-01
Grade 1-vs-Grade 3
2.712400E-01
Grade 1-vs-Grade 4
1.407400E-01
Grade 2-vs-Grade 3
1.579650E-01
Grade 2-vs-Grade 4
1.031720E-02
Grade 3-vs-Grade 4
2.005900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.258400E-01
Normal-vs-NonDiabetic
6.847600E-01
Diabetic-vs-NonDiabetic
6.634600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.932800E-01
Normal-vs-NoPancreatitis
6.800400E-01
Pancreatitis-vs-NoPancreatitis
8.991000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.032000E-01
Normal-vs-N1
6.554600E-01
N0-vs-N1
2.056800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.407800E-01
Normal-vs-TP53-NonMutant
7.442200E-01
TP53-Mutant-vs-TP53-NonMutant
1.927250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
